DK124942B - Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf. - Google Patents
Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf.Info
- Publication number
- DK124942B DK124942B DK464168AA DK464168A DK124942B DK 124942 B DK124942 B DK 124942B DK 464168A A DK464168A A DK 464168AA DK 464168 A DK464168 A DK 464168A DK 124942 B DK124942 B DK 124942B
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- acid addition
- addition salts
- analogous process
- alkanolamine derivatives
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB43927/67A GB1199037A (en) | 1967-09-27 | 1967-09-27 | Alkanolamine Derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK124942B true DK124942B (da) | 1972-12-11 |
Family
ID=10430973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK464168AA DK124942B (da) | 1967-09-27 | 1968-09-26 | Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3712927A (Direct) |
| JP (1) | JPS5220459B1 (Direct) |
| AT (3) | AT298456B (Direct) |
| BE (1) | BE721560A (Direct) |
| BR (1) | BR6802575D0 (Direct) |
| DE (1) | DE1793511A1 (Direct) |
| DK (1) | DK124942B (Direct) |
| FR (1) | FR333F (Direct) |
| GB (1) | GB1199037A (Direct) |
| IE (1) | IE32739B1 (Direct) |
| IL (1) | IL30764A (Direct) |
| NL (1) | NL6813616A (Direct) |
| NO (1) | NO123893B (Direct) |
| PL (1) | PL71423B1 (Direct) |
| SE (1) | SE357361B (Direct) |
| SU (1) | SU385433A3 (Direct) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1311521A (en) * | 1970-02-13 | 1973-03-28 | Ici Ltd | Alkanolamine derivatives |
| SE354851B (Direct) * | 1970-02-18 | 1973-03-26 | Haessle Ab | |
| US3864398A (en) * | 1972-05-01 | 1975-02-04 | Teikoku Hormone Mfg Co Ltd | Process for the preparation of acylamino alkanol derivatives |
| DE2324584A1 (de) * | 1972-06-08 | 1974-01-10 | Ciba Geigy Ag | Neue amine und verfahren zu ihrer herstellung |
| US4038414A (en) * | 1972-06-08 | 1977-07-26 | Ciba-Geigy Corporation | Amines and processes for their manufacture |
| SE386892B (sv) * | 1972-07-06 | 1976-08-23 | Haessle Ab | Forfarande for framstellning av oxaminoforeningar |
| GB1455116A (en) * | 1972-12-15 | 1976-11-10 | Ici Ltd | Pharmaceutical compositions |
| US4083992A (en) * | 1972-12-15 | 1978-04-11 | Imperial Chemical Industries Limited | Alkanolamine derivatives |
| US4171374A (en) * | 1972-12-15 | 1979-10-16 | Imperial Chemical Industries Limited | Alkanolamine derivatives |
| US4167581A (en) * | 1972-12-15 | 1979-09-11 | Imperial Chemical Industries Limited | Alkanolamine derivatives and pharmaceutical compositions and uses thereof |
| US4131685A (en) * | 1972-12-15 | 1978-12-26 | Imperial Chemical Industries Limited | Pharmaceutical compositions and uses of alkanolamine derivatives |
| US4084002A (en) * | 1973-02-28 | 1978-04-11 | Boehringer Ingelheim Gmbh | Pharmaceutical compositions containing a 1-phenoxy-2-hydroxy-3-alkynylamino-propane and method of use |
| US4016286A (en) * | 1973-02-28 | 1977-04-05 | Boehringer Ingelheim Gmbh | Pharmaceutical compositions containing a 1-phenoxy-2-hydroxy-3-alkynylamino-propane and their use as adrenolytics and hypotensives |
| US4016202A (en) * | 1973-02-28 | 1977-04-05 | Boehringer Ingelheim Gmbh | 1-Phenoxy-2-hydroxy-3-alkynylamino-propanes and salts thereof |
| AT330150B (de) * | 1973-02-28 | 1976-06-10 | Boehringer Sohn Ingelheim | Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen |
| US3957870A (en) * | 1973-07-19 | 1976-05-18 | Imperial Chemical Industries Limited | Organic compounds |
| US4039683A (en) * | 1973-08-21 | 1977-08-02 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Phenoxypropionic acid derivatives and pharmaceutical preparations containing same |
| US4239700A (en) * | 1978-10-10 | 1980-12-16 | Texaco Development Corp. | Isatoic anhydride derivatives and use as chain-extenders |
| DE3015991A1 (de) | 1980-04-25 | 1981-11-05 | C.H. Boehringer Sohn, 6507 Ingelheim | Neue 1-aryloxy-3-alkylamino-2-propanole und verfahren zur ihrer herstellung |
| DE3133678A1 (de) * | 1981-08-26 | 1983-03-17 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue l-aryloxy-3-alkylamino-2-propanole und verfahren zu ihrer herstellung |
| EP0077529B1 (de) * | 1981-10-16 | 1985-07-17 | Sanol Schwarz GmbH | Arzneimittelformulierung |
| FR2555179B1 (fr) * | 1983-11-21 | 1986-11-21 | Carpibem | Nouveaux (carbethoxy-2 furyl- ou benzofuryl-carboxamido-4 phenoxy)-1 amino-3 propanols-2 : leurs preparations et leurs applications en therapeutique |
| JPS6193417U (Direct) * | 1984-11-24 | 1986-06-17 | ||
| US4897355A (en) * | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US5545412A (en) * | 1985-01-07 | 1996-08-13 | Syntex (U.S.A.) Inc. | N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor |
| DE3640829A1 (de) * | 1986-11-28 | 1988-06-09 | Boehringer Ingelheim Kg | Neue 1-aryloxy-3-amino-2-propanole, ihre herstellung und verwendung |
| FR2637282B1 (fr) * | 1988-09-13 | 1990-12-07 | Oreal | Para-aminophenols 2-substitues et leur utilisation pour la teinture des fibres keratiniques |
| US5202487A (en) * | 1988-09-13 | 1993-04-13 | L'oreal | 2-substituted para-aminophenols and their use for dyeing keratinous fibres |
| US5541204A (en) * | 1994-12-02 | 1996-07-30 | Bristol-Myers Squibb Company | Aryloxypropanolamine β 3 adrenergic agonists |
| US6818660B2 (en) | 1996-04-09 | 2004-11-16 | Nps Pharmaceuticals, Inc. | Calcilytic compounds |
| WO1997037967A1 (en) * | 1996-04-09 | 1997-10-16 | Nps Pharmaceuticals, Inc. | Calcilytic compounds |
| US7202261B2 (en) | 1996-12-03 | 2007-04-10 | Nps Pharmaceuticals, Inc. | Calcilytic compounds |
| UY24949A1 (es) | 1997-04-08 | 2001-04-30 | Smithkline Beecham Corp | Compuestos calcilíticos |
| WO2022093849A1 (en) * | 2020-10-27 | 2022-05-05 | Arena Pharmaceuticals, Inc. | Pyrimidine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
-
1967
- 1967-09-27 GB GB43927/67A patent/GB1199037A/en not_active Expired
-
1968
- 1968-09-13 IE IE1111/68A patent/IE32739B1/xx unknown
- 1968-09-17 PL PL1968129098A patent/PL71423B1/pl unknown
- 1968-09-19 US US00760999A patent/US3712927A/en not_active Expired - Lifetime
- 1968-09-24 BR BR202575/68A patent/BR6802575D0/pt unknown
- 1968-09-24 NL NL6813616A patent/NL6813616A/xx unknown
- 1968-09-26 SE SE13017/68A patent/SE357361B/xx unknown
- 1968-09-26 DK DK464168AA patent/DK124942B/da unknown
- 1968-09-26 NO NO3811/68A patent/NO123893B/no unknown
- 1968-09-26 IL IL30764A patent/IL30764A/xx unknown
- 1968-09-27 AT AT796270A patent/AT298456B/de not_active IP Right Cessation
- 1968-09-27 DE DE19681793511 patent/DE1793511A1/de active Pending
- 1968-09-27 SU SU1283202A patent/SU385433A3/ru active
- 1968-09-27 AT AT944168A patent/AT291968B/de not_active IP Right Cessation
- 1968-09-27 JP JP43069796A patent/JPS5220459B1/ja active Pending
- 1968-09-27 AT AT796170A patent/AT298455B/de not_active IP Right Cessation
- 1968-09-27 BE BE721560D patent/BE721560A/xx unknown
- 1968-12-26 FR FR333D patent/FR333F/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NO123893B (Direct) | 1972-01-31 |
| AT291968B (de) | 1971-08-10 |
| US3712927A (en) | 1973-01-23 |
| AT298455B (de) | 1972-05-10 |
| FR333F (Direct) | 1970-10-26 |
| SU385433A3 (Direct) | 1973-05-29 |
| DE1793511A1 (de) | 1972-03-16 |
| IE32739B1 (en) | 1973-11-14 |
| PL71423B1 (en) | 1974-06-29 |
| AT298456B (de) | 1972-05-10 |
| IL30764A (en) | 1972-11-28 |
| GB1199037A (en) | 1970-07-15 |
| BR6802575D0 (pt) | 1973-04-26 |
| SE357361B (Direct) | 1973-06-25 |
| JPS5220459B1 (Direct) | 1977-06-03 |
| BE721560A (Direct) | 1969-03-27 |
| IE32739L (en) | 1969-03-27 |
| IL30764A0 (en) | 1968-11-27 |
| NL6813616A (Direct) | 1969-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK119153B (da) | Analogifremgangsmåde til fremstilling af 3-benzoyl-phenyleddikesyre-derivater eller salte deraf. | |
| DK122879B (da) | Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf. | |
| DK124824B (da) | Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf. | |
| DK123022B (da) | Analogifremgangsmåde til fremstilling af amino-monohalogen-phenylethanolaminer eller syreadditionssalte deraf. | |
| DK132411B (da) | Analogifremgangsmåde til fremstilling af pyrrylaminoketonderivater eller syreadditionssalte deraf. | |
| DK129238B (da) | Fremgangsmåde til fremstilling af morphinanderivater eller syreadditionssalte deraf. | |
| DK118187B (da) | Fremgangsmåde til fremstilling af indolderivater eller syreadditionssalte deraf. | |
| DK119059B (da) | Fremgangsmåde til fremstilling af 2-nitro-imidazolderivater eller syreadditionssalte deraf. | |
| DK137193B (da) | Analogifremgangsmåde til fremstilling af naphthacenderivater eller syreadditionssalte eller kvaternære ammoniumsalte deraf. | |
| DK139940B (da) | Analogifremgangsmåde til fremstilling af benzimidazolforbindelser eller syreadditionssalte eller metaladditionsforbindelser deraf. | |
| DK129924B (da) | Analogifremgangsmåde til fremstilling af aminoalkylaminobenzophenonderivater eller syreadditionssalte deraf. | |
| DK126327B (da) | Analogifremgangsmåde til fremstilling af derivater af p-aminoalkylbenzensulfonamid eller syreadditionssalte deraf. | |
| DK120998B (da) | Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf. | |
| DK127331B (da) | Analogifremgangsmåde til fremstilling af aryloxyisoalkyl-Δ<2>-imidazoliner eller syreadditionssalte heraf. | |
| DK120133B (da) | Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf. | |
| DK130587B (da) | Analogifremgangsmåde til fremstilling af difenylpyridazoner eller syreadditionssalt deraf. | |
| DK125129B (da) | Analogifremgangsmåde til fremstilling af oximderivater eller syreadditionssalte deraf. | |
| DK137674B (da) | Analogifremgangsmåde til fremstilling af monophenylsubstituerede oxazoler eller syreadditionssalte deraf. | |
| DK130288B (da) | Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf. | |
| DK126781B (da) | Analogifremgangsmåde til fremstilling af pyrrolidinoguanidinforbindelser eller syreadditionssalte deraf. | |
| DK128813B (da) | Analogifremgangsmåde til fremstilling af basisk substituerede thiophthalaner eller syreadditionssalte deraf. | |
| DK125921B (da) | Analogifremgangsmåden til fremstilling af thiazepinderivater eller syreadditionssalte deraf. | |
| DK123097B (da) | Fremgangsmåde til fremstilling af kasugamycinderivater eller syreadditionssalte deraf. | |
| DK115776B (da) | Analogifremgangsmåde til fremstilling af 2-(thrichlorbenzyl)-2-imidazoliner eller syreadditionssalte deraf. | |
| DK121375B (da) | Analogifremgangsmåde til fremstilling af N-aminoalkylbenzazacycloalkanderivater eller syreadditionssalte heraf. |